Create README.md

README.md

@@ -1,3 +1,54 @@
----
-license: apache-2.0
----
+---
+license: mit
+---
+
+# ANODE: Synthetic NSCLC EHR & Genomics Dataset
+
+## Title: ANODE-OncoGen High-Fidelity Synthetic Records
+
+This dataset consists of a high-density `.jsonl` collection of synthetic patient records for Non-Small Cell Lung Cancer (NSCLC), integrating clinical history with deep genomic markers.
+
+
+
+### 📋 Full Feature Specifications
+The dataset includes the following features for every patient record:
+
+#### 1. Administrative & Metadata
+* **patient_id**: Unique identifier for the synthetic patient (e.g., `ANODE_551499`).
+* **record_id**: Unique identifier for the specific clinical event.
+* **record_generation_timestamp**: ISO 8601 timestamp of data simulation.
+* **synthetic_source**: Versioning information for the Grok-4 high-fidelity simulator.
+
+#### 2. Clinical Demographics
+* **age_at_diagnosis**: Patient age in years.
+* **sex**: Biological sex (male/female).
+* **smoking_pack_years**: Quantitative history of tobacco use.
+* **ecog_performance_status**: Functional status score (0–4) indicating the patient's level of self-care.
+
+#### 3. Oncology & Histology
+* **cancer_type**: Specific malignancy (Non-small cell lung cancer).
+* **histology**: Cellular classification (e.g., Adenocarcinoma, Squamous cell carcinoma).
+* **stage_at_diagnosis**: Disease progression stage (e.g., IVA, IVB).
+* **primary_tumor_size_cm**: Diameter of the primary lesion in centimeters.
+* **metastatic_sites_count**: Numerical count of secondary tumor locations.
+
+
+
+#### 4. Genomic & Biomarker Profile
+* **driver_mutation**: Identified genetic drivers (e.g., ALK fusion, EGFR, KRAS, BRAF, or None).
+* **pd_l1_tps_percent**: Tumor Proportion Score for PD-L1 expression (0–100%).
+* **tmb_mutations_per_mb**: Tumor Mutational Burden measured in mutations per megabase.
+* **msi_status**: Microsatellite instability status (e.g., MSS).
+
+#### 5. Treatment & Survival Outcomes
+* **first_line_regimen**: Initial therapy used (e.g., carboplatin + paclitaxel + pembrolizumab).
+* **overall_survival_months**: Time elapsed from diagnosis to death or last follow-up.
+* **censored**: Boolean flag (true/false) indicating if the patient was still alive at the end of the simulation period.
+
+
+
+### 📂 Technical Format
+* **File Extension**: `.jsonl` (JSON Lines)
+* **Encoding**: UTF-8
+* **Schema Consistency**: Strict key-value pairing across all entries for programmatic parsing.
+*